2021•Cancer Immunology ImmunotherapyOpen access

Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype

Esteban E. Elías, Valeria Judith Sarapura Martínez, Mikele Amondarain, Ana Colado, Gregorio Cordini, Raimundo Bezares, Horacio Fernández Grecco, Maria Del Rosario Custidiano, Julio César Sánchez Ávalos, Gonzalo Garate, Miguel Arturo Pavlovsky, Mercedes Borge, Mirta Giordano, Romina Gamberale

Open full text 15 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Venetoclax, Syk, Cancer research, Chronic lymphocytic leukemia, Idelalisib, Leukemia, Downregulation and upregulation, Lymphoma